Imunon logo

Imunon Share Price Today

(NASDAQ: IMNN)

Imunon share price is $0.88 & ₹76.62 as on 6 Mar 2025, 2.30 'hrs' IST

$0.88

0.04

(4.14%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Imunon share price in Dollar and Rupees. Guide to invest in Imunon stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Imunon, along with analyst recommendations, forecasts, and comprehensive financials.

Imunon share price movements

  • Today's Low: $0.87
    Today's High: $0.90

    Day's Volatility :3.39%

  • 52 Weeks Low: $0.64
    52 Weeks High: $3.65

    52 Weeks Volatility :82.47%

Imunon (IMNN) Returns

PeriodImunon IncIndex (Russel 2000)
3 Months
3.54%
0.0%
6 Months
-14.56%
0.0%
1 Year
-10.5%
0.0%
3 Years
-51.91%
-11.6%

Imunon (IMNN) Key Statistics

in dollars & INR

Previous Close
$0.845
Open
$0.87
Today's High
$0.9
Today's Low
$0.8695
Market Capitalization
$12.8M
Today's Volume
$26.5K
52 Week High
$3.65
52 Week Low
$0.64
Revenue TTM
$125.0K
EBITDA
$-18.9M
Earnings Per Share (EPS)
$-1.62
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-211.21%

How to invest in Imunon Stock (IMNN) from India?

It is very easy for Indian residents to invest directly in Imunon from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Imunon stock in both Indian Rupees (INR) and US Dollars (USD). Search for Imunon or IMNN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Imunon or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Imunon shares which would translate to 0.989 fractional shares of Imunon as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Imunon, in just a few clicks!

Returns in Imunon (IMNN) for Indian investors in Rupees

The Imunon stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Imunon investment value today

Current value as on today

₹94,861

Returns

₹5,139

(-5.14%)

Returns from Imunon Stock

₹10,204 (-10.2%)

Dollar Returns

₹5,065 (+5.06%)

Indian investors sentiment towards Imunon (IMNN)

-61%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Imunon Stock from India on INDmoney has decreased by -61% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Imunon

  • Geode Capital Management, LLC

    0.96%

  • BlackRock Inc

    0.40%

  • Vanguard Group Inc

    0.34%

  • Royal Bank of Canada

    0.28%

  • Renaissance Technologies Corp

    0.23%

  • Northern Trust Corp

    0.15%

Analyst Recommendation on Imunon

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Imunon(by analysts ranked 0 to 5 stars)

Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
7
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Imunon Stock (IMNN)

What analysts predicted

Upside of 1445.45%

Target:

$13.60

Current:

$0.88

Insights on Imunon Stock (Ticker Symbol: IMNN)

  • Price Movement

    In the last 7 days, IMNN stock has moved up by 8.6%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 7.05M → 727.16K (in $), with an average decrease of 89.7% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 3 quarters, -4.78M → -13.76B (in $), with an average decrease of 50642.1% per quarter
  • IMNN vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 77.0%
  • Price to Sales

    ForIMNN every $1 of sales, investors are willing to pay $62.9, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Imunon Technicals Summary

Sell

Neutral

Buy

Imunon is currently in a neutral trading position according to technical analysis indicators.

Imunon (IMNN) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Imunon Inc logo
-2.11%
-14.56%
-10.5%
-51.91%
-51.91%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Imunon Inc logo
NA
NA
NA
-1.2
-2.11
-0.76
NA
0.29
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Imunon Inc logo
Buy
$12.8M
-51.91%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Imunon

Imunon, Inc., a clinical-stage biotechnology company, engages in the development of immunotherapies and vaccines to treat cancer and infectious diseases. The company's lead clinical program IMNN-001, a DNA-based immunotherapy for the localized treatment of ovarian cancer that is in Phase II clinical development. Its preclinical stage products include IMNN-101, a COVID-19 booster vaccine; IMNN-102 for the treatment of Lassa virus; and IMNN-201, a Trp2 tumor associated antigen cancer vaccine in melanoma. In addition, the company develops non-viral DNA technology across four modalities, such as TheraPlas for the coding of proteins and cytokines in the treatment of solid tumors; PlaCCine for the coding of viral antigens that can elicit a strong immunological response; FixPlas for the application of Imunon's DNA technology to produce universal cancer vaccines; and IndiPlas, which is in the discovery phase for the development of personalized cancer vaccines or neoepitope cancer vaccines. Imunon, Inc. was formerly known as Celsion Corporation and changed its name to Imunon, Inc. in September 2022. The company was founded in 1982 and is headquartered in Lawrenceville, New Jersey.
Organization
Imunon
Employees
0
CEO
Dr. Stacy R. Lindborg Ph.D.
Industry
Miscellaneous

Management People of Imunon

NameTitle
Mr. Michael H. Tardugno
Executive Chairman
Dr. Stacy R. Lindborg Ph.D.
President, CEO & Director
Mr. Timothy J. Tumminello CPA
Chief Accounting Officer & Controller
Ms. Susan Mary Eylward
General Counsel & Corporate Secretary
Ms. Kristin Longobardi M.B.A.
Senior Vice President of Strategic Operations
Dr. Douglas V. Faller M.D., Ph.D.
Chief Medical Officer

Important FAQs about investing in IMNN Stock from India :

What is Imunon share price today?

Imunon share price today stands at $0.88, Open: $0.87 ; Previous Close: $0.85 ; High: $0.90 ; Low: $0.87 ; 52 Week High: $3.65 ; 52 Week Low: $0.64.

The stock opens at $0.87, after a previous close of $0.85. The stock reached a daily high of $0.90 and a low of $0.87, with a 52-week high of $3.65 and a 52-week low of $0.64.

Can Indians buy Imunon shares?

Yes, Indians can invest in the Imunon (IMNN) from India.

With INDmoney, you can buy Imunon at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Imunon at zero transaction cost.

How can I buy Imunon shares from India?

It is very easy to buy Imunon from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Imunon (IMNN) be purchased?

Yes, you can buy fractional shares of Imunon with INDmoney app.

What are the documents required to start investing in Imunon stocks?

To start investing in Imunon, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Imunon Stock (IMNN)?

Today’s highest price of Imunon (IMNN) is $0.90.

Today’s lowest price of Imunon (IMNN) is $0.87.

What is today's market capitalisation of Imunon?

Today's market capitalisation of Imunon IMNN is 12.8M

What is the 52 Week High and Low Range of Imunon Stock (IMNN)?

  • 52 Week High

    $3.65

  • 52 Week Low

    $0.64

What are the historical returns of Imunon (IMNN)?

  • 1 Month Returns

    -2.11%

  • 3 Months Returns

    -14.56%

  • 1 Year Returns

    -10.5%

  • 5 Years Returns

    -51.91%

Who is the Chief Executive Officer (CEO) of Imunon ?

Dr. Stacy R. Lindborg Ph.D. is the current Chief Executive Officer (CEO) of Imunon.